Aurobindo board approves acquisition of Hyacinths Pharma - (Business Standard via NewsPoints Desk)

  • Aurobindo Pharma revealed Thursday that its board approved its acquisition of Hyacinths Pharma, Business Standard reported.
  • The drugmaker's board also approved the purchase of the 25-percent stake in Silicon Life Sciences held by ABS Mercantiles, making Silicon a completely owned subsidiary of Aurobindo.

To read more NewsPoints articles, click here.

Reference Articles